Literature DB >> 8349540

Minimum domain of the Shiga toxin A subunit required for enzymatic activity.

J E Haddad1, A Y al-Jaufy, M P Jackson.   

Abstract

The minimum sequence of the enzymatic (A) subunit of Shiga toxin (STX) required for activity was investigated by introducing N-terminal and C-terminal deletions in the molecule. Enzymatic activity was assessed by using an in vitro translation system. A 253-amino-acid STX A polypeptide, which is recognized as the enzymatically active portion of the 293-amino-acid A subunit, expressed less than wild-type levels of activity. In addition, alteration of the proposed nicking site between Ala-253 and Ser-254 by site-directed mutagenesis apparently prevented proteolytic processing but had no effect on the enzymatic activity of the molecule. Therefore, deletion analysis was used to identify amino acid residue 271 as the C terminus of the enzymatically active portion of the STX A subunit. STX A polypeptides with N-terminal and C-terminal deletions were released into the periplasmic space of Escherichia coli by fusion to the signal peptide and the first 22 amino acids of Shiga-like toxin type II, a member of the STX family. Although these fusion proteins expressed less than wild-type levels of enzymatic activity, they confirmed the previous finding that Tyr-77 is an active-site residue. Therefore, the minimum domain of the A polypeptide which was required for the expression of enzymatic activity was defined as StxA residues 75 to 268.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349540      PMCID: PMC204961          DOI: 10.1128/jb.175.16.4970-4978.1993

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  42 in total

1.  RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes.

Authors:  Y Endo; K Tsurugi
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

Review 2.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

3.  Production of Shiga-like toxin by Escherichia coli.

Authors:  L R Marques; M A Moore; J G Wells; I K Wachsmuth; A D O'Brien
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

4.  The three-dimensional structure of ricin at 2.8 A.

Authors:  W Montfort; J E Villafranca; A F Monzingo; S R Ernst; B Katzin; E Rutenber; N H Xuong; R Hamlin; J D Robertus
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

5.  Isolation and characterization of monoclonal antibodies to Shiga toxin.

Authors:  D E Griffin; M K Gentry; J E Brown
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

6.  Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.

Authors:  A Donohue-Rolfe; G T Keusch
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

8.  Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.

Authors:  A D O'Brien; G D Laveck
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.

Authors:  M J Zoller; M Smith
Journal:  DNA       Date:  1984-12

10.  Structure of a ricin mutant showing rescue of activity by a noncatalytic residue.

Authors:  Y Kim; D Mlsna; A F Monzingo; M P Ready; A Frankel; J D Robertus
Journal:  Biochemistry       Date:  1992-03-31       Impact factor: 3.162

View more
  6 in total

1.  Polyclonal antibodies to glutathione S-transferase--verotoxin subunit a fusion proteins neutralize verotoxins.

Authors:  P H M Leung; J S M Peiris; W W S Ng; W C Yam
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  The molecular mechanism of Shiga toxin Stx2e neutralization by a single-domain antibody targeting the cell receptor-binding domain.

Authors:  Alvin W H Lo; Kristof Moonens; Maia De Kerpel; Lea Brys; Els Pardon; Han Remaut; Henri De Greve
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

3.  Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.

Authors:  P R Austin; P E Jablonski; G A Bohach; A K Dunker; C J Hovde
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Cytotoxicity of a shiga toxin A subunit-CD4 fusion protein to human immunodeficiency virus-infected cells.

Authors:  A Y al-Jaufy; J E Haddad; S R King; R A McPhee; M P Jackson
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

5.  Identification of the Shiga toxin A-subunit residues required for holotoxin assembly.

Authors:  J E Haddad; M P Jackson
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

6.  Purification and characterization of a Shiga toxin A subunit-CD4 fusion protein cytotoxic to human immunodeficiency virus-infected cells.

Authors:  A Y al-Jaufy; S R King; M P Jackson
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.